Association of circulating markers with cognitive decline after radiation therapy for brain metastasis
      QxMD      Google Scholar   
Citation:
Neuro Oncol vol 25 (6) 1123-1131
Year:
2022
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
collection
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
12
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA180821, U10 CA180882, U24CA196171, UG1CA233180, UG1CA233329, UG1CA232760, U10CA180863, P30 CA015083  
Corr. Author:
 
Authors:
                                                   
Networks:
CA249, LAPS-CT018, LAPS-MN026, LAPS-PA015, NC002   
Study
Alliance-A152023
Multiple Studies, or Legacy Studies in Alliance Study:
NCCTG-N107C
Phases:
N/A, 3
Keywords:
amyloid beta, apolipoproteins, brain metastases, cognitive decline, radiation therapy